Blog Archive

Search This Blog

Monday, January 8, 2018

Next-generation CAR T-cell products for 2018

Immunotherapy for lymphoid malignancies progressed dramatically in 2017, with FDA approval of two CAR T-cell products, axicabtagene ciloleucel and tisagenlecleucel. In this interview, Yi Lin, MD, PhD,... Author: VJHemOnc Added: 01/08/2018 (Source: Oncology Tube)

from # All Medicine by Alexandros G. Sfakianakis via alkiviadis.1961 on Inoreader http://ift.tt/2AFvUby

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Blog Archive

Pages

   International Journal of Environmental Research and Public Health IJERPH, Vol. 17, Pages 6976: Overcoming Barriers to Agriculture Green T...